Replies to post #473027 on NorthWest Biotherapeutics Inc (NWBO)

[scotty3371]

No disrespect bsb, the catalyst was tld. Which was good. Everything else with the exception of some sort of partnership or an approval (months away) is not a market mover.

[vator]

End points should have been done 3 years ago. A catalyst for me is a large shareholder to convince the board to dump LP and LG.

Too pissed to consider any other catalysts.

[branster]

Basin. Put #4 on your list at the top since we will get no PR's until Journal released due to embargo. We are in a continued bottomless quiet period till then, planning by the Board will win the worst board of the year award which will be handed out at ASM. Do you think they will allow in person meeting this year to accept their award?

[fluteman]

Basin street, thank you!

[jon_k84]

I don't think you'll ever get #9. When $20+ billion buyout offers are made, companies see it as an act of bad faith when you PR that information to start a bidding war.

[ae kusterer]

BBB:# 1 by wednesday, I believe.

Basin Street Blues

Saturday, May 14, 2022 5:09:03 AM

Re: None

Post#
473027
of 473089
NEXT 2 WEEKS CATALYSTS :

1. End point changes on US Gov website BIG
2. NWBO PR end points changed and accepted by FDA HUGE
3. END POINTS MET PR
4. Journal publication including new information HUGE
5. ASCO presentation
6. ASCO New information
7. MHRA. application to be made ( or already made )
8. BLA to be made ( or already made )
9. Statement on buy out interest received ( as requested by Rago on Twitter )

[Johnnygogo]

1. Catalyst CHECK